Acomplia Back-Up Compound Could Have Clearer Obesity Effect, Sanofi Says
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s “approvable” letter for Acomplia requests an additional clinical trial in treatment of smoking cessation, but not for obesity claim, firm says.